One04 Therapeutics to present late-breaking interim Phase 1 results for CPV-104 in C3 glomerulopathy at ASN Kidney Week followed by VirtualKOL Event ... .
General Secretary and President Lâm said the CPV wishes to further strengthen exchanges and cooperation with the CPC, including the sharing of experience in Party building and development.
One04 Therapeutics launches on encouraging CPV-104 Phase 1 interim results and plans to expand clinical development to include kidney diseases and dry AMD... .
Agreement Entered into by CPVRenewables... The Financing Agreement includes a term loan of approximately $250 million, primarily intended to repay CPV Renewables' project loans ... of CPV Renewables.